These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 10677386)

  • 1. Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I.
    Forst T; De La Tour DD; Kunt T; Pfützner A; Goitom K; Pohlmann T; Schneider S; Johansson BL; Wahren J; Löbig M; Engelbach M; Beyer J; Vague P
    Clin Sci (Lond); 2000 Mar; 98(3):283-90. PubMed ID: 10677386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of C-peptide on microvascular blood flow and blood hemorheology.
    Forst T; Kunt T
    Exp Diabesity Res; 2004; 5(1):51-64. PubMed ID: 15198371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects ex vivo and in vitro of insulin and C-peptide on Na/K adenosine triphosphatase activity in red blood cell membranes of type 1 diabetic patients.
    Djemli-Shipkolye A; Gallice P; Coste T; Jannot MF; Tsimaratos M; Raccah D; Vague P
    Metabolism; 2000 Jul; 49(7):868-72. PubMed ID: 10909997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-peptide increases forearm blood flow in patients with type 1 diabetes via a nitric oxide-dependent mechanism.
    Johansson BL; Wahren J; Pernow J
    Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E864-70. PubMed ID: 12799312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus.
    Forst T; Kunt T; Pohlmann T; Goitom K; Engelbach M; Beyer J; Pfützner A
    J Clin Invest; 1998 May; 101(10):2036-41. PubMed ID: 9593759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-peptide, Na+,K(+)-ATPase, and diabetes.
    Vague P; Coste TC; Jannot MF; Raccah D; Tsimaratos M
    Exp Diabesity Res; 2004; 5(1):37-50. PubMed ID: 15198370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of erythrocyte Na+-K+ ATPase activity and cholesterol and oxidative stress in patients with type 2 diabetes mellitus.
    Konukoglu D; Kemerli GD; Sabuncu T; Hatemi H
    Clin Invest Med; 2003 Dec; 26(6):279-84. PubMed ID: 14690302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of human proinsulin C-peptide on erythrocyte deformability in patients with Type I diabetes mellitus.
    Kunt T; Schneider S; Pfützner A; Goitum K; Engelbach M; Schauf B; Beyer J; Forst T
    Diabetologia; 1999 Apr; 42(4):465-71. PubMed ID: 10230651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-dependent transition from H(2)O(2)-extracellular signal-regulated kinase- to O(2)-nitric oxide-dependent mechanisms in the stimulatory effect of leptin on renal Na+/K+/-ATPase in the rat.
    Marciniak A; Borkowska E; Kedra A; Rychlik M; Beltowski J
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1216-24. PubMed ID: 17184504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide decreases renal medullary Na+, K+-ATPase activity through cyclic GMP-protein kinase G dependent mechanism.
    Bełtowski J; Marciniak A; Wójcicka G; Górny D
    J Physiol Pharmacol; 2003 Jun; 54(2):191-210. PubMed ID: 12832721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-peptide does not affect ocular blood flow in patients with type 1 diabetes.
    Polska E; Kolodjaschna J; Berisha F; Malec MM; Simader C; Bayerle-Eder M; Roden M; Schmetterer L
    Diabetes Care; 2006 Sep; 29(9):2034-8. PubMed ID: 16936149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proinsulin C-peptide prevents type-1 diabetes-induced decrease of renal Na+-K+-ATPase alpha1-subunit in rats.
    Nordquist L; Shimada K; Ishii T; Furuya DT; Kamikawa A; Kimura K
    Diabetes Metab Res Rev; 2010 Mar; 26(3):193-9. PubMed ID: 20225182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of insulin on microvascular blood flow and endothelial cell function in the postprandial state in patients with Type 1 diabetes.
    Forst T; Forst S; Strunk K; Löbig M; Welter K; Kazda C; Pfützner A
    J Diabetes Complications; 2005; 19(3):128-32. PubMed ID: 15866056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute, local effects of iontophoresed insulin and C-peptide on cutaneous microvascular function in Type 1 diabetes mellitus.
    Delaney C; Shaw J; Day T
    Diabet Med; 2004 May; 21(5):428-33. PubMed ID: 15089786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Physiological effects of C-peptide].
    Tsimaratos M
    Nephrologie; 2004; 25(5):155-61. PubMed ID: 15455788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is l-arginine infusion an adequate tool to assess endothelium-dependent vasodilation of the human renal vasculature?
    Schlaich MP; Jacobi J; John S; Delles C; Fleischmann I; Schmieder RE
    Clin Sci (Lond); 2000 Oct; 99(4):293-302. PubMed ID: 10995594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of erythrocyte (Na(+)-K+)ATPase activity in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria.
    Mimura M; Makino H; Kanatsuka A; Asai T; Yoshida S
    Horm Metab Res; 1994 Jan; 26(1):33-8. PubMed ID: 8150421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of acute hyperglycaemia on sodium handling and excretion of nitric oxide metabolites, bradykinin, and cGMP in Type 1 diabetes mellitus.
    Simková R; Kazdová L; Karasová L; Simek S; Pelikánová T
    Diabet Med; 2004 Sep; 21(9):968-75. PubMed ID: 15317600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of aldose reductase inhibitor (Ponalrestat) on erythrocyte Na,K-ATPase activity in non-insulin-dependent diabetic patients with polyneuropathy.
    Umeda F; Noda K; Hashimoto T; Yamashita T; Nawata H
    Diabetes Res; 1989 Nov; 12(3):125-9. PubMed ID: 2561396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Na+,K+-ATPase activity is inhibited in cultured intestinal epithelial cells by endotoxin or nitric oxide.
    Suzuki Y; Lu Q; Xu DZ; Szabó C; Haskó G; Deitch EA
    Int J Mol Med; 2005 May; 15(5):871-7. PubMed ID: 15806312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.